» Authors » Dingwei Xue

Dingwei Xue

Explore the profile of Dingwei Xue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 406
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Zhu S, Zhou Z, Wang Z, Zhuang W, Xue D, et al.
Eur J Med Res . 2024 Mar; 29(1):151. PMID: 38429762
Background: Urosepsis is a life-threatening organ disease in which pathogenic microorganisms in the urine enter the blood through the vessels, causing an imbalance in the immune response to infection. The...
2.
Yu C, Xu L, Ye L, Zheng Q, Hu H, Ni K, et al.
World J Surg Oncol . 2023 Feb; 21(1):46. PMID: 36782247
Background: To evaluate the early functional and oncological outcomes of single-port robot-assisted perineal radical prostatectomy (sp-pRARP) using the da Vinci XI system and analyze its learning curve using the cumulative...
3.
Yu W, Guo B, Zhang H, Zhou J, Yu X, Zhu L, et al.
Sci Bull (Beijing) . 2023 Jan; 64(6):410-416. PMID: 36659732
Significantly reduced tissue scattering of fluorescence signals in the second near-infrared (NIR-II, 1,000-1,700 nm) spectral region offers opportunities for large-depth in vivo bioimaging. Nowadays, most reported works concerning NIR-II fluorescence...
4.
Ding L, Zheng Q, Lin Y, Wang R, Wang H, Luo W, et al.
Clin Transl Med . 2023 Jan; 13(1):e1156. PMID: 36597139
Background: Circular RNAs (circRNAs) have been reported to play a significant role in tumorigenesis. However, the detailed function of circRNA in prostate cancer (PCa) is still largely unknown. Methods: We...
5.
Ren L, Jiang M, Xue D, Wang H, Lu Z, Ding L, et al.
Int J Biol Sci . 2022 Aug; 18(13):5207-5220. PMID: 35982887
Bladder cancer is one of the most common and deadly cancer worldwide. Current chemotherapy has shown limited efficacy in improving outcomes for patients. Nitroxoline, an old and widely used oral...
6.
7.
Ding L, Wang R, Zheng Q, Shen D, Wang H, Lu Z, et al.
J Exp Clin Cancer Res . 2022 Jun; 41(1):187. PMID: 35650605
Background: Circular RNA (circRNA) is a novel class noncoding RNA (ncRNA) that plays a critical role in various cancers, including prostate cancer (PCa). However, the clinical significance, biological function, and...
8.
Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, et al.
Mol Cancer . 2022 May; 21(1):111. PMID: 35538475
Background: Sunitinib resistance can be classified into primary and secondary resistance. While accumulating research has indicated several underlying factors contributing to sunitinib resistance, the precise mechanisms in renal cell carcinoma...
9.
Zhou H, Lu Z, Zhang Y, Li M, Xue D, Zhang D, et al.
ACS Appl Mater Interfaces . 2022 Feb; 14(7):8705-8717. PMID: 35148047
Theranostic agents with fluorescence in the second near-infrared (NIR-II) window, especially in its long-wavelength region, and NIR-II-excitable photothermal effect is promising but challenging in tumor diagnosis and therapy. Here, we...
10.
Ni K, Xue D, Li G
Transl Cancer Res . 2022 Feb; 10(11):4694-4701. PMID: 35116324
Background: Single-port robotic-assisted radical laparoscopic prostatectomy has emerged as a novel robotic-assisted radical laparoscopic prostatectomy in recent years, arousing wide attention. However, single-port robotic-assisted radical laparoscopic prostatectomy using Si da...